Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Safilo Group SpASAFLF 63 EV-to-EBIT is 9.33 as of Jul. 28, 2026. GuruFocus rates SAFLF with a GF Score™ of 63/100 and a GF Value™ of $1.18 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Safilo Group SpA ranks better than 80.04% on this metric.
Safilo Group SpA (OTCPK:SAFLF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Safilo Group SpA's Enterprise Value for the quarter that ended in Dec. 2025 was $929 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Safilo Group SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safilo Group SpA EV-to-EBIT Related Terms
Safilo Group SpA EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Safilo Group SpA's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Safilo Group SpA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Safilo Group SpA EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Safilo Group SpA's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Safilo Group SpA's EV-to-EBIT falls into.
Safilo Group SpA's current Enterprise Value is $800 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Safilo Group SpA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Safilo Group SpA (SAFLF) has a EV-to-EBIT of 9.33 as of Jul. 28, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Safilo Group SpA and its competitors. According to the industry distribution chart, Safilo Group SpA ranks #93 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 20%.
Is Safilo Group SpA's EV-to-EBIT too high?
Safilo Group SpA's current EV-to-EBIT is 9.33. The Medical Devices & Instruments industry median EV-to-EBIT is 18.67. Safilo Group SpA's value of 9.33 is 50% below this industry median. Based on the distribution chart, Safilo Group SpA ranks #93 out of 466 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Safilo Group SpA has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Safilo Group SpA's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Safilo Group SpA ranks #93 out of 466 companies for EV-to-EBIT. This places Safilo Group SpA in the top 20% of its industry — outperforming the majority of peers. The industry median EV-to-EBIT is 18.67. Safilo Group SpA's value of 9.33 is 50% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.67, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Safilo Group SpA's current EV-to-EBIT of 9.33 is 50% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Safilo Group SpA and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Safilo Group SpA's current EV-to-EBIT is 9.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Safilo Group SpA stock overvalued right now?
Based on GuruFocus' analysis, Safilo Group SpA (SAFLF) is currently considered Significantly Overvalued. The stock's GF Value™ is $1.18, compared to a current price of $2.01 — trading 70.3% above its estimated fair value. The current EV-to-EBIT is 9.33 and 50% below the Medical Devices & Instruments industry median of 18.67. Safilo Group SpA's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Safilo Group SpA (SAFLF), the current EV-to-EBIT is 9.33 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Safilo Group SpA (SAFLF) Overvalued in 2026?
Based on GuruFocus' analysis, Safilo Group SpA stock appears to be overvalued.
The current stock price of $2.01 is trading 70.3% above its estimated GF Value™ of $1.18.
GuruFocus considers Safilo Group SpA to be Significantly Overvalued.
Key valuation signals for SAFLF:
EV-to-EBIT: 9.33
GF Value™: $1.18 vs. price of $2.01 (70.3% above fair value)
Industry Position: 50% below the Medical Devices & Instruments median (#93 of 466)
No single metric tells the full story. See the SAFLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Safilo Group SpA makes sunglasses and prescription eyewear. It is engaged in design, production, and wholesale distribution of its products through a network of independent distributors and commercial subsidiaries. Its products are sold through the Carrera, Smith, Polaroid and Oxydo brands, as well as a range of other licensed brands. The company operates solely through the wholesale segment channels and divides itself into the following four geographical segments: Europe, America, and Asia. The company earns the majority of its revenue from the Europe business segment.
63GF Score
Get the complete analysis for SAFLF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAFLF has been successfully added to your 
